IsraelDesks Weekly Roundup, March 7th 2025
M&A, capital markets activity, and venture investment are driving Israel’s resilient economy, with significant deals across medtech, energy, defense, and infrastructure.
Boston Scientific acquired Israeli #medtech firm SoniVie for USD 360m, with an additional USD 180m tied to regulatory approval. Gornitzky GNY and Latham & Watkins advised Boston Scientific, while K&L Gates represented SoniVie. In the #energy sector, The Phoenix Insurance secured a stake in Dorad Energy at a NIS 2.8b valuation, with legal counsel from ERM - Epstein Rosenblum Maoz . In capital markets, Elad Software Systems launched the first TASE IPO of 2025, raising NIS 80m with guidance from Pearl Cohen , while Yesodot Eitanim secured USD 47m in its own TASE listing, supported by S. Horowitz & Co. . Meanwhile, Carter Ledyard & Milburn LLP outlined key updates on EDGAR Next for securities compliance for filings in the U.S.
In our weekly catch up with Israel Desks, we speak to U.S. law firm 普衡律师事务所 , which noted: “We see a subset of Israeli companies pulling ahead of their peers in Israel and globally, and positioning themselves to be market leaders. These companies often operate in the cybersecurity space or otherwise have SaaS business models and technology that is widely commercialized outside of Israel."
Investor confidence in Israeli tech remains high. Startups raised USD 550m in February. U.S. VC firm Andreessen Horowitz expanded its Israel investments, while life sciences funding surged 25% to USD 2.7b. Defense technology gained traction as Texas Venture Partners launched a DoD Readiness Program, advised by Meitar | Law Offices .?
Click here to read the weekly update: https://tinyurl.com/ycxhmh64